CRISPR Therapeutics AG ($CRSP)
Filing Information
| Accession Number | 0001193125-26-251817 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 1, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
23,786
Total Value
$210,577.32
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Shares | โ | May 28, 2026 | Exercise/Conversion | 10,000 | โ | โ | 23,143 | Direct | โ | View Details | |
Chief Medical Officer | Common Shares | โ | May 29, 2026 | Sale | 3,786 | $55.62 | $210,577.32 | 19,357 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | May 28, 2026 | Exercise/Conversion | 10,000 | โ | โ | 20,000 | Direct | โ | View Details |